FDA
approval
· 2024-08-14
FDA Approved: ORPHENADRINE CITRATE — Supplemental Application (Lupin Pharmaceuticals, Inc.)
Summary
FDA approved Lupin Pharmaceuticals' supplemental application for Orphenadrine citrate, enabling a new generic version of the muscle relaxant to be marketed. The…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
SUPPL AP for ORPHENADRINE CITRATE (ORPHENADRINE CITRATE)